IONIS PHARMACEUTICALS INC
IONS
63 insider filings · Latest: Jun 26, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Nov 12, 2024 | Nov 12 9:15 PM | LOSCALZO JOSEPH | Proposed Sale | 13,508 | $38.88 | $525.2K | — | View → |
| Feb 2, 2024 | Sep 5 1:33 AM | Monia Brett P | Proposed Sale | 23,907 | $49.37 | $1.2M | — | View → |
| Feb 1, 2024 | Sep 5 1:29 AM | Cadoret-Manier Onaiza | Proposed Sale | 2,162 | $49.60 | $107.2K | — | View → |
| Feb 1, 2024 | Sep 5 1:27 AM | BENNETT C FRANK | Proposed Sale | 1,885 | $49.52 | $93.3K | — | View → |
| Feb 2, 2024 | Sep 5 1:25 AM | HOUGEN ELIZABETH L | Proposed Sale | 2,162 | $49.54 | $107.1K | — | View → |
| Feb 2, 2024 | Sep 5 1:24 AM | O'NEIL PATRICK R. | Proposed Sale | 1,995 | $49.67 | $99.1K | — | View → |
| Feb 2, 2024 | Sep 5 1:23 AM | Monia Brett P | Proposed Sale | 23,907 | $49.37 | $1.2M | — | View → |
| Feb 2, 2024 | Sep 5 1:21 AM | Geary Richard S | Proposed Sale | 1,995 | $50.04 | $99.8K | — | View → |
| Feb 2, 2024 | Sep 5 1:20 AM | Schneider Eugene | Proposed Sale | 2,106 | $49.59 | $104.4K | — | View → |
| Feb 2, 2024 | Sep 5 1:19 AM | Swayze Eric | Proposed Sale | 1,940 | $49.56 | $96.1K | — | View → |
← Previous
Page 10 of 10
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 9, 2026 | Mar 11 8:19 PM | Brett P MoniaDirector, Chief Executive Officer | Option Exercise | 114,351 | $60.89 | 34,103(D) | View → |
| Mar 10, 2026 | Mar 11 8:18 PM | Kyle JenneEVP, Chf GL Pdt Str Ofcr | Option Exercise | 37,277 | $46.10 | 32,601(D) | View → |
| Mar 4, 2026 | Mar 5 11:14 PM | Joseph LoscalzoDirector | Option Exercise | 200 | $38.06 | 10,968(D) | View → |
| Mar 3, 2026 | Mar 5 11:14 PM | Joseph LoscalzoDirector | Option Exercise | 832 | $38.06 | 11,168(D) | View → |
| Mar 3, 2026 | Mar 5 11:14 PM | Joseph Klein IIIDirector | Option Exercise | 16,000 | $42.88 | 0(D) | View → |
| Mar 3, 2026 | Mar 5 11:14 PM | Allene M. DiazDirector | Option Exercise | 40,321 | $41.08 | 0(D) | View → |
| Mar 3, 2026 | Mar 5 11:14 PM | Shannon L. DeversEVP, Chief Human Resources Ofc | Option Exercise | 20,106 | $52.87 | 8,877(D) | View → |
| Mar 3, 2026 | Mar 5 11:13 PM | BENNETT C FRANKEVP, Chief Scientific Officer | Option Exercise | 65,089 | $60.89 | 0(D) | View → |
| Mar 4, 2026 | Mar 5 11:13 PM | Joseph BaroldiEVP, Chief Business Officer | Option Exercise | 439 | $56.78 | 3,866(I) | View → |
| Mar 3, 2026 | Mar 5 11:13 PM | Joseph BaroldiEVP, Chief Business Officer | Option Exercise | 1,699 | $56.78 | 4,104(I) | View → |
| Feb 2, 2026 | Feb 4 9:06 PM | BENNETT C FRANKEVP, Chief Scientific Officer | Option Exercise | 65,089 | $60.89 | 0(D) | View → |
| Jan 15, 2026 | Jan 21 1:21 AM | Michael J. YangDirector | Option Exercise | 1,930 | — | 7,150(D) | View → |
| Jan 15, 2026 | Jan 21 1:21 AM | Eric SwayzeEVP Research | Grant/Award | 35,700 | $0.00 | 611(I) | View → |
| Jan 15, 2026 | Jan 21 1:21 AM | Eric SwayzeEVP Research | Option Exercise | 21,477 | — | 386(I) | View → |
| Jan 15, 2026 | Jan 21 1:21 AM | Eugene SchneiderEVP, Chf Clinical Develop Ofcr | Option Exercise | 21,685 | — | 39,251(D) | View → |
| Jan 15, 2026 | Jan 21 1:21 AM | Eugene SchneiderEVP, Chf Clinical Develop Ofcr | Grant/Award | 35,475 | $0.00 | 48,926(D) | View → |
| Jan 15, 2026 | Jan 21 1:20 AM | Patrick R. O'NeilEVP CLO & General Counsel | Option Exercise | 21,473 | — | 39,251(D) | View → |
| Jan 15, 2026 | Jan 21 1:20 AM | Patrick R. O'NeilEVP CLO & General Counsel | Grant/Award | 35,475 | $0.00 | 48,926(D) | View → |
| Jan 15, 2026 | Jan 21 1:20 AM | Brett P MoniaDirector, Chief Executive Officer | Grant/Award | 156,585 | $0.00 | 205,719(D) | View → |
| Jan 15, 2026 | Jan 21 1:20 AM | Brett P MoniaDirector, Chief Executive Officer | Option Exercise | 89,145 | — | 163,014(D) | View → |